Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Gene A. Wetzstein"'
Publikováno v:
Immunological Medicine, Vol 46, Iss 1, Pp 58-60 (2023)
AbstractPrimary immunodeficiency (PI) patients may still experience persistent viral and bacterial respiratory infections with ongoing treatments. We report a challenging case of a PI patient who experienced recurrent viral respiratory infections des
Externí odkaz:
https://doaj.org/article/207c97fff3ed4af9b7ad56e70bb914e4
Publikováno v:
Immunological Medicine. 46:58-60
Primary immunodeficiency (PI) patients may still experience persistent viral and bacterial respiratory infections with ongoing treatments. We report a challenging case of a PI patient who experienced recurrent viral respiratory infections despite rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc49887e097a124951b3eddc5a976f55
https://doi.org/10.1080/25785826.2022.2151170
https://doi.org/10.1080/25785826.2022.2151170
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:HSR21-074
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b3a5f590515d3e384bfef2d9883f9ff
https://doi.org/10.6004/jnccn.2020.7770
https://doi.org/10.6004/jnccn.2020.7770
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:HSR20-099
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ca88c010d8fd105de14cfbbf46d8408
https://doi.org/10.6004/jnccn.2019.7417
https://doi.org/10.6004/jnccn.2019.7417
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f51c110416642c7e5c7a3e16197b292f
https://doi.org/10.2139/ssrn.4001250
https://doi.org/10.2139/ssrn.4001250
Autor:
John N. Greene, Mohamed A. Kharfan-Dabaja, Rod Quilitz, Mai Otsuka, Gene A. Wetzstein, Ramon L. Sandin
Publikováno v:
Infectious Diseases in Clinical Practice. 20:319-325
Background: Vancomycin-resistant Enterococcus fascium (VRE) are rapidly emerging nosocomial pathogens in the United States and worldwide. Vancomycin resistance is recognized to be an independent risk factor for increased morbidity and mortality among
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e19f64046dc4258c4c6d02964072926
https://doi.org/10.1097/ipc.0b013e3182639da4
https://doi.org/10.1097/ipc.0b013e3182639da4
Autor:
Timothy J. George, Viet Q. Ho, Samantha Price, Mohamed A. Kharfan-Dabaja, Gene A. Wetzstein, Alan F. List, Jeffrey E. Lancet, Rami S. Komrokji, Hugo F. Fernandez, Javier Pinilla-Ibarz
Publikováno v:
Leukemia Research. 35:301-304
There is no standard salvage regimen for AML. We retrospectively compared two commonly used regimens at our institution: CLAG and MEC. The complete response rate (CR) was 37.9% for CLAG (n=97) and 23.8% for MEC (n=65) (P=0.048), with median overall s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b696e821c11cbc12827d8ecc2779a301
https://doi.org/10.1016/j.leukres.2010.09.002
https://doi.org/10.1016/j.leukres.2010.09.002
Autor:
Weiwei Zhu, Daohai Yu, Alan F. List, Jeffrey E. Lancet, Celeste M. Bello, Rami S. Komrokji, Gene A. Wetzstein
Publikováno v:
Cancer. 117:1463-1469
BACKGROUND: Secondary acute myeloid leukemia (AML) from an antecedent myelodysplastic syndrome (MDS)/myeloproliferative neoplasm is associated with a poor prognosis. The authors evaluated predictive factors in patients with secondary AML treated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36e3435196b01a45202d001f4601396e
https://doi.org/10.1002/cncr.25598
https://doi.org/10.1002/cncr.25598
Publikováno v:
Cancer Control. 19:245-247
Background Bendamustine is indicated for the treatment of chronic lymphocytic leukemia (CLL) and rituximab refractory indolent non-Hodgkin lymphoma. Clinical trials have reported a 25% incidence of infusion-related reactions (IRRs) in patients receiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74a674f9730ab19cee2c285e4e980dde
https://doi.org/10.1177/107327481201900309
https://doi.org/10.1177/107327481201900309
Autor:
Stephen K Aiken, Gene A. Wetzstein
Publikováno v:
Cancer Control. 9:426-431
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4a58215bc56299387c2ea3d25a489c8
https://doi.org/10.1177/107327480200900509
https://doi.org/10.1177/107327480200900509